证券代码：002372 证券简称：伟星新材 浙江伟星新型建材股份有限公司投资者关系活动记录表 编号：2025-002 | | √特定对象调研 □分析师会议 | | --- | --- | | 投资者关系活动类 | □媒体采访 □业绩说明会 | | 别 | □新闻发布会 □路演活动 | | | □现场参观 □其他 | | 参与单位名称及人 | | | 员姓名 | 泰康资产：徐占杰；华泰证券：方晏荷。 | | 时间 | 2025 年 1 月 17 日 | | 地点 | 公司会议室 | | 上市公司接待人员 | 谭梅、李晓明、章佳佳、陈银琼 | | 姓名 | | | | 1、竣工端持续下滑，请问公司零售业务的需求在哪里？ | | | 答：公司零售业务的需求主要来自毛坯新房和存量房的装修。房地产竣工量下 | | | 滑意味着新房供给的数量减少，但存量房的供给仍在逐年提升，整体的市场空间依 | | | 然较大。 | | | 2、请具体介绍一下公司的"星管家"服务？ | | | 答：公司在行业内首创"星管家"服务，旨在为业主提供安全可靠的管道系统 | | | 的同时，通过"三免一告知"的方式，减少安装隐患，真正解除其后顾 ...

证券代码：300913 证券简称：兆龙互连 浙江兆龙互连科技股份有限公司 投资者关系活动记录表 编号：2025-001 | | 特定对象调研 □分析师会议  | | --- | --- | | 投资者关系活动 | □媒体采访 □业绩说明会 | | 类别 | □新闻发布会 □路演活动 | | | 现场参观 □其他 | | 参会人员 | 华泰证券：王兴、宗亮、王珂、高名垚 | | | 长城基金：杨维维、谭小兵 | | | 嘉实基金：孟丽婷 | | | 新华资产：何晨宇、马川、阴舒 | | | 中泰证券：陈宁玉、颜小玮 | | 时间 | 2025 年 1 月 16 日、2025 年 1 月 17 日 | | 地点 | 电话会议、现场会议 | | 上市公司接待人 | 副总经理兼董事会秘书姚云萍女士、证券事务代表沈圆月女士 | | 员姓名 | | | 投资者关系活动 | 首先参观公司展厅，然后回答了提问，具体内容如下： | | | 1、公司高速产品目前的产能情况如何？扩产进度如何？ | | | 答：目前公司的高速产品订单处于相对饱和的状态，随着新 | | | 采购的高速产品设备陆续交付，产能正在逐步提升。公司高速产 ...

Group 1: Operational Performance - The Vietnam industrial park was established in March 2024, with limited orders and expected losses for the year due to initial focus on customer inspections and employee training [1] - The Bangladesh industrial park continues to show growth, but is undergoing technological upgrades to improve production levels [1] Group 2: Market Share and Product Structure - The company's market share in the zipper business is relatively small due to a lack of comprehensive industry statistics [1] - In terms of product structure, nylon zippers account for the highest proportion, while plastic and metal zippers are roughly equal [1] Group 3: Business Segmentation - As per the 2024 semi-annual report, the button business accounted for 40.39% and the zipper business accounted for 54.82% of total revenue [2] - The company leverages product diversity, fashionability, innovation, and rapid market response to enhance customer share [2] Group 4: Production and Profitability - The current proportion of fast-response orders is lower compared to futures orders, but the company is enhancing production efficiency through smart manufacturing strategies [2] - Future gross margin trends will be influenced by raw material costs, product structure, and scale effects, with a focus on sustainable profit levels [2] Group 5: Dividend Policy and Capacity - The company adheres to a sustainable development philosophy in its annual profit distribution, considering profitability and shareholder interests [2] - With the construction of overseas production bases, the company expects an increase in overseas capacity, but domestic capacity will remain dominant in the short term [2]

| | 5、根据公告，公司这几年新项目投资较大，有无考虑再融资计 | | --- | --- | | | 划？ | | | 答：公司以前负债率较低，随着公司业务规模的不断扩大及新 | | | 项目的建设需要，对资金的需求也将逐步增加。公司将根据经 | | | 营情况合理安排资金，结合监管政策规定、公司业务发展需求 | | | 和资金需求等因素，综合考虑多元化融资渠道。若有再融资相 | | | 关规划，公司将按照相关规定及时履行信息披露义务。 | | | 6、公司后续还会保持稳定的现金分红政策嘛？ | | | 答：公司目前仍处于发展期，新项目建设仍需要投入一定量的 | | | 资金。公司股利分配方案应从公司盈利情况和战略发展的实际 | | | 需要出发，兼顾股东的即期利益和长远利益，保持持续、稳定 | | | 的利润分配制度，注重对投资者稳定、合理的回报。公司上市 | | | 后，充分考虑中小投资者的利益诉求，保持了相对较为稳定的 | | | 分红政策。后续，公司将会结合项目投资进展情况以及经营业 | | | 绩情况，保持合理的分红节奏。 | | 附件清单（如 | 无 | | 有） | | | 日期 | 202 ...

Company Overview - Daon Co., Ltd. was established in 2002, specializing in high-performance thermoplastic elastomers, modified plastics, color masterbatches, biodegradable materials, and copolyester materials [3] - The company has an annual production capacity of 500,000 tons for modified plastics, 90,000 tons for thermoplastic elastomers, 30,000 tons for color masterbatches, and 60,000 tons for copolyester materials [3] - Daon has developed the first domestically produced TPV production line with independent intellectual property rights, breaking international monopolies in the TPV industry [3] Sales and Clientele - Haier is the largest customer, accounting for 31.81% of sales in 2023 [5] - Other major downstream appliance clients include Hisense, Joyoung, Xiaomi, Liren, Midea, and Meiling [5] Future Strategies - The company plans to enhance R&D investments in modified plastics, thermoplastic elastomers, color masterbatches, biodegradable materials, and copolyester materials [4] - Daon aims to integrate subsidiaries for improved resource utilization and expand its business scale through both organic growth and acquisitions [4] Market Impact - The 2024 national policy on trade-in programs is expected to positively impact the industry, with further policy expansions anticipated in January 2025 [6] - HNBR products have broad application prospects in aerospace, oil exploration, automotive, and new energy sectors, facilitating import substitution [7] Mergers and Acquisitions - The acquisition of Daon Titanium Industry is aimed at leveraging synergies in the chemical new materials sector, enhancing product and technology collaboration [9] - Daon Titanium's financials as of September 30, 2024, include total assets of 1.127 billion CNY and a net profit of 100 million CNY for the first three quarters [10] Revenue Sources - Modified plastics contribute approximately 70% to the company's revenue, primarily used in automotive and home appliance sectors [11] - High-margin products like TPV, HNBR, and copolyester are expected to drive future growth through import substitution [11]

| | □分析师会议 ■特定对象调研 | | --- | --- | | 投资者关系 | □媒体采访 □业绩说明会 | | 活动类别 | □新闻发布会 □路演活动 | | | □其他 □现场参观 | | 活动参与人员 | 华鑫证券 张涵、罗笛箫 | | 时间 | 2025 年 1 月 16 日 10:30-11:30 | | 地点 | 深圳市南山区高新中一道长园新材料港 F 栋 4 楼会议室 | | 形式 | 现场会议 | | 公司接待人员 | 董事会秘书、财务负责人：韩海凤 | | | 证券事务代表：周小菡 | | | 1、公司在数据通讯行业的布局？ | | | 公司自成立以来坚持自主创新研发，持续推进品牌建设，数据通讯 | | | 行业是公司非常重要的目标细分市场之一。 | | | 数据中心对其配电系统的供电连续性及电源可靠性要求很高，公司 | | | 产品定位中高端市场，可为数据中心提供电源自动转换开关、断路器等 产品，确保数据中心的可靠运行。多年来，公司产品持续应用于运营商 | | | 数据中心建设及部分单体数据中心建设项目中。在通讯领域，公司持续 | | | 加大研发创新，基于通讯基站对配电开关设备 ...

Group 1: Investor Relations Activity - The investor relations activity was an analyst meeting held online on January 16, 2025, with participation from various financial institutions [3] - Attendees included representatives from Minsheng Securities, Shangyin Fund, and others, with the company represented by Chairman Fu Guojun and Secretary Ren Jianying [3] Group 2: Business Strategy in Hainan - The company is promoting the "Hainan Style Car" project, focusing on two core service directions: community charging services and tourist vehicle rental services [4] - The community service aims to provide convenient and efficient energy replenishment for residents, while the tourist service caters to both short-term visitors and seasonal residents [4] Group 3: Business Models - The "Hainan Style Car" business includes a purchase + battery model for residents, allowing them to acquire a vehicle and battery simultaneously, with battery swaps available at charging stations [5] - For tourists, a rental + service model is offered, with flexible billing options: hourly for short-term rentals and monthly for long-term stays [5] Group 4: Regional Preferences and Market Presence - The company prioritizes southern regions and large cities for its charging and battery swap business, considering climate and user density [6] - The charging business has been established in over ten provinces, with significant market share in certain areas, and plans to expand battery swap facilities in communities with existing charging stations [6] Group 5: Strategic Layout in Tourism - The company is collaborating with Hainan Tourism Investment to develop the "Hainan Style Car" brand, focusing on building a charging network along the island's scenic routes [7] - This initiative aims to enhance the tourism experience by providing charging stations for electric bicycles at key tourist spots [7]

投资者关系活动记录表 投资者关系 活动类别 特定对象调研 □ 媒体采访 □ 新闻发布会 ☑ 现场参观 □ 其他 分析师会议 业绩说明会 路演活动 □ 一对一沟通 参与单位名称 及人员姓名 万联证券：周思健、陈思远 长江证券：黄志华 东方财富：邹佩玲、卢华银、黄海航 长城证券：郭茂延、李峰、冯晓慰、关勇梅、赵昀鹏、梁韵诗 平安银行：孙丹丹 及 7 名个人投资者 时间 2025 年 01 月 16 日 地点 东莞智动力电子科技有限公司办公楼一楼会议室 上市公司 出席人员 副总经理、董事会秘书：方江先生 证券事务代表：鄢芷女士 投资者关系活动 主要内容介绍 一、公司介绍 公司主要从事消费电子功能性器件、结构性器件、光学组件及可穿 戴组件的研发、生产和销售，为客户提供智能手机、平板电脑、智能穿 戴、智能家居等消费电子产品及新能源汽车相关产品的一体化解决方 案。公司主要客户涵盖三星、OPPO、vivo、谷歌等全球知名品牌。 二、互动交流 问题 1：请介绍公司年度分红情况及回报股东的情况 公司始终高度重视对股东的投资回报。在 2022 年及 2023 年期间， | | | 由于公司业绩出现波动，未能满足现金分红条件，因此 ...

Company Overview - Weike Technology specializes in the research, design, manufacturing, and sales of precision injection molds and has expanded into the production and sales of injection parts and health products, serving various industries including automotive and electronics [1][2]. - The company has developed into a large-scale "mold-integration" production enterprise and has established overseas production bases in Germany, Malaysia, Mexico, the USA, Singapore, and Vietnam since 2019 to enhance its global operational layout [2]. Financial Performance - In the first three quarters of 2024, the revenue breakdown by sector is as follows: Fashion Appliances 33%, Automotive 29%, Home 18%, with significant growth in the New Energy, Small Appliances, and Outdoor Home sectors [3][4]. - The company aims for a net profit growth target of 20% for 2025, which aligns with its employee equity incentive plan [16]. Product and Market Strategy - The New Energy sector has seen rapid growth since early 2022, with sales of components for electric vehicle batteries and capacitors increasing significantly in 2023 [5][7]. - The Fashion Appliances sector's growth is attributed to a complete manufacturing platform that reduces costs and accelerates product delivery, with plans to expand into new product categories [9]. Competitive Advantages - Weike Technology holds over 500 patents, including 27 authorized invention patents, and has been recognized as a key enterprise in precision injection molds and a national-level technology center [2]. - The company benefits from a strong customer base, primarily consisting of Fortune 500 companies, which provides a stable revenue stream and favorable payment terms [10][11]. Challenges and Risk Management - The company faces longer payment cycles from domestic New Energy clients but maintains sufficient funds to manage cash flow effectively [8]. - To mitigate risks associated with accounts receivable, the company conducts credit assessments and closely monitors payment progress [8]. International Sales and Production - In the first three quarters of 2024, the company's export ratio is approximately 42%, with actual figures expected to exceed 60% due to certain sales classified as domestic [13]. - The overseas sales distribution is as follows: North America 29%, Europe 30%, and Asia 39% [13]. Future Outlook - The company plans to increase overseas investments to enhance its international competitiveness while maintaining a primary focus on domestic production capacity [17]. - Weike Technology is committed to increasing its dividend payout, with a 67% dividend rate for 2023, and aims to share its growth with investors [16].

Group 1: Company Overview and Performance - In 2024, the veterinary pharmaceutical segment benefited from improvements in both upstream and downstream operations, as well as expansion into overseas markets, leading to strong sales performance [2][3] - The company's sixth-phase project commenced production in October 2024, primarily for the production of oxytetracycline, with some used as raw material for another product, strong mycin, while the remainder will be sold externally [2] - The approval of the sheep-use premix of chlortetracycline in November 2024 is expected to drive significant domestic demand, with an anticipated increase of over 20,000 tons in future usage [2][3] Group 2: Research and Development Initiatives - A strategic cooperation agreement was signed with Shanghai Jiao Tong University to develop new synthetic biology products and improve existing product processes, with expected results in the coming years [2][3] - The establishment of the Chengdu Agricultural Technology Center and the joint venture with Zhongnong Duchuang aims to address challenges in bio-agriculture and bio-pharmaceuticals, focusing on new technologies and product commercialization [3] - The company is applying for P3 laboratory research qualifications, which is expected to enhance its R&D capabilities and overall competitiveness, with approval anticipated by the end of 2025 [3] Group 3: Product Development and Market Strategy - The pet business segment is being strategically developed, with a new subsidiary established in Shanghai and several products already on the market, including deworming medications and rabies vaccines [3] - The company plans to launch several vaccines in 2025, including those for pseudorabies and bovine nodular dermatitis, as well as a new four-in-one vaccine for cats and dogs [3] Group 4: Market Position and Competitive Advantages - Following policy adjustments in 2020, the usage of chlortetracycline has increased significantly, with application amounts rising from 25-75 PPM to 400-600 PPM, leading to a potential 50%-100% increase in customer usage [4] - The company is the largest global producer of chlortetracycline, with a high market share and strong product quality, which positions it favorably against competitors [4] - Approximately 80% of the company's vaccine clients are from the top 100 industry players, indicating strong market competitiveness and a focus on quality [4]